☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
High Bleeding Risk
Abbott's XIENCE Stent Receives the US FDA's Approval for Shortest Blood Thinner Course in Patients with High Bleeding Risk
July 1, 2021
Medtronic Reports Results of Resolute Onyx DES in Onyx ONE Global Study for High-Bleeding Risk Patients with One-Month DAPT
September 27, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.